Ezio Bonvini - 22 Feb 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Sr VP, Research & CSO
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Issuer symbol
MGNX
Transactions as of
22 Feb 2023
Net transactions value
-$23,704
Form type
4
Filing time
24 Feb 2023, 15:34:38 UTC
Previous filing
17 Feb 2023
Next filing
21 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $0 +9,375 +8.2% $0.000000 123,799 22 Feb 2023 Direct F1
transaction MGNX Common Stock Tax liability $23,704 -3,619 -2.9% $6.55 120,180 22 Feb 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -9,375 -100% $0.000000* 0 22 Feb 2023 Common Stock 9,375 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.